Advocacy Day & the critical need for research dollars On March 18, FPN staff and board members traveled to Washington, D.C. to speak up for the 30 million Americans who have peripheral neuropathy (PN). Our visit was urgent because earlier in March, the U.S. Congress passed a bill that cut funding for medical research by 57%. Read […]
Protect PN research from proposed funding cuts Proposed cuts to federal research funding threaten critical studies across many conditions, including neuropathy. Research funding, which totals billions annually, supports essential work on nerve regeneration, pain management, and new treatments for PN. As soon as today, the House will be voting on a continuing resolution to fund […]
FPN funds scholarship award on CIPN Tiffany Li, PhD, has been awarded the 2025 Clinical Research Training Scholarship (CRTS) to support her important research on chemotherapy-induced peripheral neuropathy (CIPN). The CRTS is a multi-year scholarship program providing funding for emerging experts in neuropathy, supporting their efforts to advance treatments, prevention, or cures for neuropathy. Read […]
As the chilly winds of winter give way to the gentle warmth of spring, we find ourselves amidst a season of transformation and renewal. With each new bud and blossom, we are reminded of the potential for growth and progress in the field of neuropathy research. Please join us as we look forward to brighter […]
Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, […]
Read More… from FPN Funds IMAGiNe Study for anti-MAG Research
Happiest of holidays to you and yours from the Foundation for Peripheral Neuropathy. We are so grateful for your continued support in our organization, whether you already made your gift to our year end campaign, told someone about us on Giving Tuesday or recently received your PN swag. Thank you and stay safe, cozy and healthy during this season! […]
Introduction to Anti-MAG Neuropathy Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system – resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, […]
Read More… from TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING
The Foundation for Peripheral Neuropathy (FPN) is pleased that the IMAGiNe study protocol has been approved for publication in the Journal of the Peripheral Nervous System. The focus of this international study is a rare autoimmune cause of PN. It is identified by high levels of the IgM protein in the blood of affected patients, […]
Read More… from Study Protocol on IgM Anti-Mag Neuropathy Released
Through the generosity of our donors, we’re able to support the IMAGiNe study with a $150,000 research grant to fund new patient enrollment. $90,000 of these funds, spent in 2022, resulted in over 150 new patients enrolling in the study. The IMAGiNe Study The IMAGiNe study is an international research collaborative focused on patients with […]
Read More… from FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research
Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s own immune system attacks cells that are specific in maintaining a healthy peripheral nervous system. As these cells are destroyed by antibodies, they lose function and create problems in both […]